A detailed history of Dimensional Fund Advisors LP transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 2,261,091 shares of VNDA stock, worth $10.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,261,091
Previous 2,013,807 12.28%
Holding current value
$10.8 Million
Previous $11.4 Million 6.8%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$4.61 - $6.34 $1.14 Million - $1.57 Million
247,284 Added 12.28%
2,261,091 $10.6 Million
Q2 2024

Aug 09, 2024

BUY
$3.91 - $6.5 $1.14 Million - $1.9 Million
292,172 Added 16.97%
2,013,807 $11.4 Million
Q1 2024

May 10, 2024

SELL
$3.47 - $4.61 $854,834 - $1.14 Million
-246,350 Reduced 12.52%
1,721,635 $7.08 Million
Q4 2023

Feb 07, 2024

SELL
$3.38 - $4.58 $664,416 - $900,304
-196,573 Reduced 9.08%
1,967,985 $8.3 Million
Q3 2023

Nov 09, 2023

BUY
$4.28 - $6.57 $920,949 - $1.41 Million
215,175 Added 11.04%
2,164,558 $9.35 Million
Q2 2023

Aug 09, 2023

SELL
$5.9 - $6.95 $4.92 Million - $5.8 Million
-834,307 Reduced 29.97%
1,949,383 $12.8 Million
Q1 2023

May 12, 2023

SELL
$6.18 - $7.99 $433,477 - $560,434
-70,142 Reduced 2.46%
2,783,690 $18.9 Million
Q4 2022

Feb 09, 2023

BUY
$6.87 - $10.96 $816,540 - $1.3 Million
118,856 Added 4.35%
2,853,832 $21.1 Million
Q3 2022

Nov 10, 2022

BUY
$9.44 - $11.76 $518,737 - $646,223
54,951 Added 2.05%
2,734,976 $27 Million
Q2 2022

Aug 12, 2022

BUY
$9.31 - $11.84 $3.88 Million - $4.94 Million
416,866 Added 18.42%
2,680,025 $29.2 Million
Q1 2022

May 13, 2022

BUY
$10.84 - $16.55 $2.49 Million - $3.8 Million
229,581 Added 11.29%
2,263,159 $25.6 Million
Q4 2021

Feb 09, 2022

BUY
$15.69 - $21.14 $1.63 Million - $2.19 Million
103,696 Added 5.37%
2,033,578 $31.9 Million
Q3 2021

Nov 12, 2021

SELL
$15.35 - $21.27 $560,965 - $777,312
-36,545 Reduced 1.86%
1,929,882 $33.1 Million
Q2 2021

Aug 12, 2021

BUY
$15.71 - $21.51 $3.74 Million - $5.12 Million
238,066 Added 13.77%
1,966,427 $42.3 Million
Q1 2021

May 14, 2021

BUY
$13.42 - $20.28 $2.36 Million - $3.57 Million
176,123 Added 11.35%
1,728,361 $26 Million
Q4 2020

Feb 25, 2021

BUY
$9.77 - $13.81 $15.2 Million - $21.4 Million
1,552,238 New
1,552,238 $20.4 Million

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $270M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.